Format

Send to

Choose Destination
See comment in PubMed Commons below
Haematologica. 2004 Mar;89(3):360-1.

Circulating endothelin-3 levels in patients with sickle cell disease during hydroxyurea treatment.

Abstract

Abnormal adhesion of red blood cells to the endothelium and the production of cytokines and vasoactive substances, such as endothelin-1 contribute to the pathogenesis of microvascular occlusion in sickle cell disease (SCD), even during the steady state. Endothelin-3 (ET-3) is a vasoconstrictive agent, which has not yet been studied in SCD.

PMID:
15020278
[Indexed for MEDLINE]
Free full text
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for HighWire
    Loading ...
    Support Center